Vitality Watch

Dossier clinicaltrials trial early 23-sep-2026
Small or early-phase human trial or pilot study

Tai Chi Exercise to Improve Quality of Life and Depression in Elderly With Sarcopenia

Key claim: An eight-week Tai Chi program is being tested against standard elderly exercise for whether it improves SarQoL quality-of-life scores and reduces GDS-15 depressive symptoms in older adults with sarcopenia.

Abstract

This study aims to evaluate the effects of Tai Chi exercise on quality of life and depressive symptoms in elderly with sarcopenia. Sarcopenia is characterized by a progressive decline in skeletal muscle mass and muscle strength, which may contribute to impaired physical function, reduced quality of life, and an increased risk of adverse health outcomes among older adults. Specifically, this study investigates the effects of an eight-week Tai Chi exercise program on health-related quality of life, assessed using the Sarcopenia Quality of Life (SarQoL) questionnaire, and depressive symptoms, assessed using the Geriatric Depression Scale-15 (GDS-15), in elderly individuals diagnosed with sarcopenia.

The primary research question of this study is whether an eight-week Tai Chi exercise program can improve quality of life and reduce depressive symptoms in elderly individuals with sarcopenia. Furthermore, this study aims to determine whether Tai Chi exercise results in greater improvements in SarQoL scores and GDS-15 scores compared with a control group participating in standard elderly exercise.

Why this matters

An eight-week Tai Chi program is being tested against standard elderly exercise for whether it improves SarQoL quality-of-life scores and reduces GDS-15 depressive symptoms in older adults with sarcopenia.

Source

Link

Briefing card

Tai Chi Exercise to Improve Quality of Life and Depression in Elderly With Sarcopenia
Stage: trial early · clinicaltrials · 23-sep-2026

An eight-week Tai Chi program is being tested against standard elderly exercise for whether it improves SarQoL quality-of-life scores and reduces GDS-15 depressive symptoms in older adults with sarcopenia.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07831356

build build 880 · 2bcef25 · 2026-11-18